Article
Genetic polymorphism of interleukin-1 receptor antagonist in Type 1 diabetic children.
Pediatric research - 1 May 2022
Abed Neveen T, Ramadan Ismail A, Mohammed Shuzan A, El-Shanawany Eman M
Abstract excerpt
BACKGROUND: Interleukin-1 receptor antagonist (IL1RN) variable number tandem repeats (VNTRs) are not fully understood in Type 1 diabetes mellitus (T1DM). It may affect IL1RN level and modify the disease risk. We aimed to study IL1RN VNTR polymorphism in Egyptian children with T1DM to clarify its potential role as a risk factor for T1DM and its effect on plasma IL1RN level. METHODS: A case-controlled study...
Topics
Join the communities discussing this publication.
